These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 26965791

  • 1. Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial.
    Xu L, Liu S, Guan M, Xue Y.
    Med Sci Monit; 2016 Mar 11; 22():810-7. PubMed ID: 26965791
    [Abstract] [Full Text] [Related]

  • 2. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
    Schumacher HR, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J.
    BMJ; 2002 Jun 22; 324(7352):1488-92. PubMed ID: 12077033
    [Abstract] [Full Text] [Related]

  • 3. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial.
    Li T, Chen SL, Dai Q, Han XH, Li ZG, Wu DH, Zhang X, Gu JR, Yang NP, Sun LY, Zhang MJ, Li XF, Bao CD.
    Chin Med J (Engl); 2013 Jun 22; 126(10):1867-71. PubMed ID: 23673101
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
    Rubin BR, Burton R, Navarra S, Antigua J, Londoño J, Pryhuber KG, Lund M, Chen E, Najarian DK, Petruschke RA, Ozturk ZE, Geba GP.
    Arthritis Rheum; 2004 Feb 22; 50(2):598-606. PubMed ID: 14872504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of Huzhang Granule, a compound Chinese herbal medicine, for acute gouty arthritis: A double-blind, randomized controlled trial.
    Wang H, Chen ST, Ding XJ, Kuai L, Hua L, Li X, Wang YF, Zhang M, Li B, Wang RP, Zhou M.
    J Integr Med; 2024 May 22; 22(3):270-278. PubMed ID: 38553375
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
    Zhang S, Zhang Y, Liu P, Zhang W, Ma JL, Wang J.
    Clin Rheumatol; 2016 Jan 22; 35(1):151-8. PubMed ID: 26099603
    [Abstract] [Full Text] [Related]

  • 8. Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.
    Man CY, Cheung IT, Cameron PA, Rainer TH.
    Ann Emerg Med; 2007 May 22; 49(5):670-7. PubMed ID: 17276548
    [Abstract] [Full Text] [Related]

  • 9. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.
    Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP.
    Arthritis Res Ther; 2013 Feb 01; 15(1):R25. PubMed ID: 23375025
    [Abstract] [Full Text] [Related]

  • 10. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
    Croom KF, Siddiqui MA.
    Drugs; 2009 Jul 30; 69(11):1513-32. PubMed ID: 19634927
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Etoricoxib.
    Cochrane DJ, Jarvis B, Keating GM.
    Drugs; 2002 Jul 30; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Etoricoxib (Arcoxia)].
    Leclercq P, Malaise MG.
    Rev Med Liege; 2004 May 30; 59(5):345-9. PubMed ID: 15270001
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.
    Rheumatology (Oxford); 2007 Mar 30; 46(3):496-507. PubMed ID: 16936327
    [Abstract] [Full Text] [Related]

  • 18. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
    Balazcs E, Sieper J, Bickham K, Mehta A, Frontera N, Stryszak P, Popmihajlov Z, Peloso PM.
    BMC Musculoskelet Disord; 2016 Oct 13; 17(1):426. PubMed ID: 27737664
    [Abstract] [Full Text] [Related]

  • 19. Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis.
    Bressan E, Tonussi CR.
    Inflamm Res; 2008 Dec 13; 57(12):586-92. PubMed ID: 19109739
    [Abstract] [Full Text] [Related]

  • 20. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC, Yoo WH, Kang SB, Park YW, Kim SS, Moon KH, Song YW, Min BW, Cho YJ, Moon SH, Bin SI, Baek HJ, Shim SC, Lee SW, Yoo DH, Mehta A, Skuban A, Cukrow DM, Vandormael K, Yan L.
    Curr Med Res Opin; 2014 Dec 13; 30(12):2399-408. PubMed ID: 25133963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.